FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
07/03/2023
Back to search
Official data from USPTO
QIAREACH
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
QIAREACH
ST13
US500000079321551Class
1, 5, 9
Filing
79321551
Registration
6993724
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
35
Latest update
07/03/2023
Trademark type
Word
Nice classes
1, 5, 9
Filing date
03/16/2021
Registration date
03/07/2023
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
03/07/2023
Last transaction
03/07/2023
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
4
Owner type
99
Owner location
DE
Examiner
HACK, ANDREA R
Law office
L80
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
Qiagen GmbH
Representatives
Randolph E. Digges, III Rankin, Hill & Clark LLP
Technical classification
Nice Classes
Class 1Class 5Class 9
Vienna Codes
No Vienna codes available.
Goods and services
Class 1
Chemical and biochemical preparations for use in industry and research; biotechnological products for use in industry and research usediagnostic reagentsbufferspeptides and antigens; chemical and biochemical preparations for non-medical use; biotechnological products for non-medical purposesdiagnostic reagentsbufferspeptides and antigens; chemicalbiochemical and biotechnological products for use in in-vitro diagnostic for non-medical purposeschemically treated lateral flow test strips for non-medical purposesfor detection of pathogens and viruses and bacteriadiagnostic reagentsbufferspeptides and antigens; chemicalbiochemical and biotechnological products for use in scientific and laboratory researchdiagnostic reagentsbufferspeptidesantigens and chemically treated lateral flow test strips for detection of pathogensvirusesbacteria; chemicalbiochemical and biotechnological preparations for use in in-vitro diagnostic for scientific research or laboratory use; reagent kits comprising chemicalbiochemical and biotechnological preparations for industrial and scientific purposes; reagent kits comprising chemicalbiochemical and biotechnological preparations for use in in-vitro diagnostic for non-medical purposes; chemicalbiochemical and biotechnological test kits comprised of diagnostic reagentsbufferspeptides and antigens for in-vitro detection of pathogensviruses and bacteria for laboratory or research use; biochemicalsantibodies for in-vitro scientific or research use; chemicalbiochemical and biotechnological kits comprising antibodies for in-vitro detection of pathogensviruses and bacteria for scientific or research use; chemicalbiochemical and biotechnological products for medical and pharmaceutical researchchemically treated lateral flow test strips for detection of pathogensviruses and bacteria
Class 5
Chemicalbiochemical and biotechnological preparations for medical and veterinary purposespreparations for treating diseases or conditions caused by pathogensviruses and bacteria; chemicalbiochemical and biotechnological preparations for human in-vitro medical diagnostic purposesfor diagnosing diseases or conditions caused by pathogensviruses and bacteria; chemicalbiochemical and biotechnological reagents and preparations for human in-vitro medical diagnostic purposes; chemicalbiochemical and biotechnological products for human in-vitro medical diagnostic purposeschemically treated lateral flow test strips for detection of pathogensviruses and bacteria; kits comprising chemicalbiochemical and biotechnological preparations for human in-vitro medical diagnostic purposes; chemicalbiochemical and biotechnological preparations for medical and pharmaceutical purposes; diagnostic kits comprising chemical preparations for human in-vitro diagnostic for medical or pharmaceutical purposesfor diagnosing diseases or conditions caused by pathogensviruses and bacteria; diagnostic kits comprising chemicalbiochemical and biotechnological preparations for human in-vitro diagnostic for detection of pathogensviruses and bacteria for medical or pharmaceutical purposes; biochemicalsantibodies for use in human in vitro medical diagnostic use; chemicalbiochemical and biotechnological kits for human in-vitro diagnostic use comprising antibodies for in-vitro detection of pathogensviruses and bacteria
Class 9
Scientific apparatusesinstruments and devices for researchdevelopment and examination purposeschromatography deviceslaboratory robotsrobotic workstations being laboratory robotsoptoelectronic devices for handling and analyzing nucleic acidsproteinsenzymeschemicals; structural and replacement parts for chromatography deviceslaboratory robotsrobotic workstations being laboratory robotsoptoelectronic devices for handling and analyzing nucleic acidsproteinsenzymeschemicals; downloadable software for use in scientific and medical researchsoftware for detectingidentifyingquantifying and specifying pathogensviruses and bacteria; scientific apparatusesinstruments and deviceschromatography deviceslaboratory robotsrobotic workstations being laboratory robotsoptoelectronic devices for handling and analyzing nucleic acidsproteinsenzymeschemicals; downloadable software for detection of pathogensviruses and bacteriain particular detection by specific antibodies
Publications
History of USPTO decisions and trademark events.
35 publications found
FICS
FINAL DISPOSITION NOTICE SENT TO IB
06/09/2023
FIMP
FINAL DISPOSITION PROCESSED
06/09/2023
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
06/07/2023
OPNX
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
03/20/2023
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
03/07/2023
R.PR
REGISTERED-PRINCIPAL REGISTER
03/07/2023
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
03/01/2023
OPNR
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
03/01/2023
GPNX
NOTIFICATION PROCESSED BY IB
12/21/2022
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
12/20/2022
PUBO
PUBLISHED FOR OPPOSITION
12/20/2022
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
11/30/2022
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
11/30/2022
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
11/30/2022
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
11/11/2022
XAEC
EXAMINER'S AMENDMENT ENTERED
11/11/2022
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
11/11/2022
GNEA
EXAMINERS AMENDMENT E-MAILED
11/11/2022
CNEA
EXAMINERS AMENDMENT -WRITTEN
11/11/2022
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
05/19/2022
GNFR
FINAL REFUSAL E-MAILED
05/19/2022
CNFR
FINAL REFUSAL WRITTEN
05/19/2022
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
05/17/2022
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
05/16/2022
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
05/16/2022
RFNT
REFUSAL PROCESSED BY IB
12/06/2021
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
11/18/2021
RFRR
REFUSAL PROCESSED BY MPU
11/18/2021
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
10/22/2021
CNRT
NON-FINAL ACTION WRITTEN
10/21/2021
DOCK
ASSIGNED TO EXAMINER
10/18/2021
MAFR
APPLICATION FILING RECEIPT MAILED
10/12/2021
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
10/06/2021
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
09/30/2021
Continuous trademark protection
Get notified about every new filing that threatens QIAREACH or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.